{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T02:33:28Z","timestamp":1771554808140,"version":"3.50.1"},"reference-count":65,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2023,4,3]]},"DOI":"10.1080\/14740338.2023.2130888","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T10:22:49Z","timestamp":1664533369000},"page":"331-338","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of adverse events of bamlanivimab, bamlanivimab\/etesevimab used for COVID-19 based on FAERS database"],"prefix":"10.1080","volume":"22","author":[{"given":"Yunfei","family":"Zhao","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhengzhou Railway Vocational and Technical College, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingsong","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxin","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"e_1_3_3_3_1","unstructured":"WHO Coronavirus (COVID-19) Dashboard. World Health Organization. [cited 2022 Mar 6]. Available from: https:\/\/covid19.who.int.\/"},{"key":"e_1_3_3_4_1","unstructured":"Symptoms of COVID-19. Centers for disease control and prevention. [cited 2022 Mar 6]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html#seek-medical-attention"},{"key":"e_1_3_3_5_1","unstructured":"Questions and answers on COVID-19: Medical information. European Centre for Disease Prevention and Control. [cited 2022 Mar 6]. Available from: https:\/\/www.ecdc.europa.eu\/en\/covid-19\/questions-answers\/questions-answers-medical-info"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/IPC.0000000000000952"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26269"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248009"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2021000299"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00510-x"},{"key":"e_1_3_3_11_1","first-page":"089719002110481","article-title":"COVID-19: a review of potential treatments (corticosteroids, remdesivir, tocilizumab, bamlanivimab etesevimab, and casirivimab\/imdevimab) and pharmacological considerations","author":"Nhean S","year":"2021","unstructured":"Nhean S, Varela ME, Nguyen YN, et al. COVID-19: a review of potential treatments (corticosteroids, remdesivir, tocilizumab, bamlanivimab etesevimab, and casirivimab\/imdevimab) and pharmacological considerations. J Pharm Pract. 2021;08971900211048139.","journal-title":"J Pharm Pract"},{"key":"e_1_3_3_12_1","unstructured":"Lilly_COVID-19_Antibodies_Fact_Sheet. Eli lilly and company. [cited 2022 Mar 6]. Available from: https:\/\/assets.ctfassets.net\/srys4ukjcerm\/2UxR1Ezm3MVVPkKBVtPVeq\/d6132f383fc7c8b7dba878d0a456377e\/Lilly_COVID-19_Antibodies_Fact_Sheet.pdf"},{"key":"e_1_3_3_13_1","unstructured":"Molnupiravir. U.S. national library of medicine. [cited 2022 Mar 6]. Available from: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=Molnupiravir&cntry=&state=&city=&dist=&Search=Search"},{"key":"e_1_3_3_14_1","unstructured":"Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002). U.S. national library of medicine. [cited 2022 Mar 6]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04575597?term=Molnupiravir+AND+COVID-19&draw=2&rank=3"},{"key":"e_1_3_3_15_1","unstructured":"Sotrovimab. U.S. National library of medicine. [cited 2022 Mar 6]. Available from: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=sotrovimab&cntry=&state=&city=&dist="},{"key":"e_1_3_3_16_1","unstructured":"A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals. U.S. national library of medicine. [cited 2022 Mar 6]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05210101?term=sotrovimab&draw=2&rank=1"},{"key":"e_1_3_3_17_1","unstructured":"Baricitinib. U.S. National library of medicine. [cited 2022 Mar 6]. Available from: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=baricitinib&cntry=&state=&city=&dist=&Search=Search"},{"key":"e_1_3_3_18_1","unstructured":"A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER-PEDS) (COV-BARRIER). U.S. national library of medicine. [cited 2022 Mar 6]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05074420?term=baricitinib&draw=2&rank=2"},{"key":"e_1_3_3_19_1","unstructured":"COVID-19 Treatment Guidelines. National institutes of health. [cited 2021 Oct 15]. Available from: https:\/\/files.covid19treatmentguidelines.nih.gov\/guidelines\/covid19treatmentguidelines.pdf"},{"key":"e_1_3_3_20_1","unstructured":"Frequently Asked Questions on the Revocation of the Emergency Use Authorization for Bamlanivimab Administered Alone (EUA 90). U.S. food and drug administration. [cited 2021 Oct 14]. Available from: https:\/\/www.fda.gov\/media\/147639\/download"},{"key":"e_1_3_3_21_1","unstructured":"Bamlanivimab and Etesevimab. U.S. food and drug administration. [cited 2021 Oct 9]. Available from: https:\/\/www.fda.gov\/media\/145801\/download"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1962846"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14459"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1799975"},{"key":"e_1_3_3_25_1","unstructured":"COVID-19 Emergency Use Authorization (EUA) FAERS Public Dashboard. U.S. food and drug administration. [cited 2021 Sep 27]. Available from: https:\/\/fis.fda.gov\/sense\/app\/dc0a5af3-51ac-4e10-9791-cdcfa900bd4f\/sheet\/7a47a261-d58b-4203-a8aa-6d3021737452\/state\/analysis"},{"key":"e_1_3_3_26_1","unstructured":"What is a Serious Adverse Event?U.S. Food and drug administration. [cited 2022 Mar 6]. Available from: https:\/\/www.fda.gov\/safety\/reporting-serious-problems-fda\/what-serious-adverse-event"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2006.09.002"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02799-9"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1742"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04037.x"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1695"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-30-93"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2033130"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.8828"},{"issue":"3","key":"e_1_3_3_35_1","first-page":"H331","article-title":"Cardiovascular effects of radioactive microsphere suspensions and Tween 80 solutions","volume":"232","author":"Millard RW","year":"1977","unstructured":"Millard RW, Baig H, Vatner SF. Cardiovascular effects of radioactive microsphere suspensions and Tween 80 solutions. A J Physiol. 1977;232(3):H331\u20134.","journal-title":"A J Physiol"},{"key":"e_1_3_3_36_1","unstructured":"Vaccine mechanism of harm exposed. Janak CA. [cited 2021 Oct 14]. Available from: http:\/\/www.renewamerica.com\/columns\/janak\/150210"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.5.1185"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-020-0754-0"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30221-0"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04575-3"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04486-3"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00565"},{"issue":"6","key":"e_1_3_3_47_1","first-page":"e8460","article-title":"Neurological and psychological effects of coronavirus (COVID-19): an overview of the current era pandemic","volume":"5","author":"Rahman J","year":"2020","unstructured":"Rahman J, Muralidharan A, Quazi SJ, et al. Neurological and psychological effects of coronavirus (COVID-19): an overview of the current era pandemic. Cureus. 2020;5;12(6):e8460.","journal-title":"Cureus"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029849"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102685"},{"issue":"2","key":"e_1_3_3_50_1","first-page":"81","article-title":"Diagnosis and treatment plan for COVID-19(trial version 8 revision)","volume":"14","author":"China NHCotPsRo","year":"2021","unstructured":"China NHCotPsRo. Diagnosis and treatment plan for COVID-19(trial version 8 revision). Chinese Journal of Clinical Infectious Diseases 2021; 14(2): 81\u201388","journal-title":"Chinese Journal of Clinical Infectious Diseases"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61024-1"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005615117"},{"key":"e_1_3_3_53_1","unstructured":"Eli Lilly and Company Limited antibody combination (bamlanivimab\/etesevimab - COVID19 - Article-5(3) procedure: Assessment report. European medicines agency (EMA). [cited 2021 Oct 13]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/eli-lilly-company-limited-antibody-combination-bamlanivimab\/etesevimab-covid19-article-53-procedure-assessment-report_en.pdf"},{"key":"e_1_3_3_54_1","unstructured":"LABEL: BAMLANIVIMAB injection solution. Eli lilly and company. [cited 2021 Oct 23]. Available from: https:\/\/www.dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=c7e9d8a6-e8c2-4681-9362-51d5bdbae00d#"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.08.032"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab331"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0202"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01964882"},{"key":"e_1_3_3_59_1","unstructured":"Robertson S. Histamine storage and release. News-Medical. [cited 2021 Oct 14]. Available from: https:\/\/www.news-medical.net\/health\/Histamine-Storage-and-Release.aspx."},{"key":"e_1_3_3_60_1","unstructured":"Bamlanivimab Side Effects. Drugs.com. [cited 2021 Oct 20]. Available from: https:\/\/www.drugs.com\/sfx\/bamlanivimab-side-effects.html"},{"key":"e_1_3_3_61_1","volume-title":"Chest Pain","author":"Johnson K","year":"2021","unstructured":"Johnson K, Ghassemzadeh S. Chest Pain. Treasure Island (FL): StatPearls Publishing; 2021."},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-239"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00333-w"},{"key":"e_1_3_3_64_1","unstructured":"Respiratory failure. Wikipedia. [cited 2021 Oct 6]. Available from: https:\/\/en.wikipedia.org\/wiki\/Respiratory_failure"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01365-2020"},{"key":"e_1_3_3_66_1","unstructured":"U.S.National heart lung and blood lnstitute. How Is Pulmonary Embolism Diagnosed?. [cited 2021 Oct 10]. Available from: https:\/\/web.archive.org\/web\/20160407071108\/http:\/\/www.nhlbi.nih.gov\/health\/health-topics\/topics\/pe\/diagnosis"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0968-3"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2130888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T19:56:17Z","timestamp":1726602977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2130888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,3]]}},"alternative-id":["10.1080\/14740338.2023.2130888"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2130888","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-11-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}